Clinical Trials Browser

Adenocarcinoma, Urinary Bladder Diseases, Urinary Bladder Neoplasms, Breast Diseases, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Colonic Neoplasms, Genital Diseases, Male, Intestinal Neoplasms, Kidney Diseases, Kidney Neoplasms, Melanoma, Neoplasms, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Prostatic Diseases, Prostatic Neoplasms, Skin Diseases, Urogenital Neoplasms, Urologic Diseases, Urologic Neoplasms, Colorectal Neoplasms, Neuroectodermal Tumors, Nevi and Melanomas, Neuroendocrine Tumors

NCT01210716 2013-09-23

Evaluation of Therapeutic Plasma Exchange (TPE) Procedure Using the AMICUS Device

Phase 3 Completed

37 enrolled 7 charts

Genitourinary

Autoimmune Diseases, Hematologic Diseases, Kidney Diseases, Nervous System Diseases, Paraproteinemias

NCT00460798 2010-11-16

SUNIKA

Completed

356 enrolled 8 charts

Genitourinary

Carcinoma, Renal Cell, Kidney Diseases, Kidney Neoplasms, Urogenital Neoplasms

NCT00886353 2009-12-31

Safety and Tolerability Study of APN01 (Recombinant Human Angiotensin Converting Enzyme 2)

Phase 1 Completed

22 enrolled

Genitourinary

Cardiovascular Diseases, Kidney Diseases, Lung Diseases

NCT00035334 2006-02-14

Study of the Safety and Efficacy of NC-503 in Secondary (AA) Amyloidosis

Phase 2/3 Completed

150 enrolled

GastrointestinalGenitourinaryPlasma cell

Amyloidosis, Arthritis, Rheumatoid, Gastrointestinal Diseases, Kidney Diseases, Neoplasm Metastasis, Nephrotic Syndrome, Familial Mediterranean Fever

Clinical Trials

JAVELIN Renal 101

A Phase I Study of TAS-102 in Patients With Advanced Solid Tumors With Renal Impairment

JAVELIN Renal 100

A Pharmacokinetic Study of AMG 386 in Cancer Subjects With Normal and Impaired Renal Function

A Study of V934/V935 Vaccine in Cancer Participants With Selected Solid Tumors (V934-002)

Evaluation of Therapeutic Plasma Exchange (TPE) Procedure Using the AMICUS Device

SUNIKA

Safety and Tolerability Study of APN01 (Recombinant Human Angiotensin Converting Enzyme 2)

Study of the Safety and Efficacy of NC-503 in Secondary (AA) Amyloidosis